TMCnet News
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against PetMed Express, Inc.Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PetMed Express, Inc. (NASDAQ: PETS) resulting from allegations that PetMed may have issued materially misleading business information to the investing public. On August 23, 2017, Aurelius Value published an article alleging that PetMed targets opioid users with Google (News - Alert) ads and other marketing techniques aimed at facilitating the abuse of opioids. On this news, shares of PetMed fell $3.19 per share or over 8% to close at $36.22 per share on August 23, 2017, damaging investors. Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by PetMed investors. If you purchased shares of PetMed on or before August 23, 2017, please visit the firm's website at http://www.rosenlegal.com/cases-1199.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected]. Follow us for updates on LinkedIn (News - Alert): https://www.linkedin.com/company/the-rosen-law-firm or on Twitter (News - Alert): https://twitter.com/rosen_firm. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170823006109/en/ |
